glp-1 injection price Novo Nordisk launches Wegovy weight-loss pill in US, triggering war | Pharmaceuticals industry The Rising Tide of GLP-1

TriNetX cohort study (547,993 matched adults, published in JAAD International, 2026): GLP1 users were 40 percent more likely to develop nonscarring hair loss, 64 percent more likely to develop pattern thinning, and 76 percent more likely to experience stress-related shedding

BMI distribution has shifted modestly toward lower weight categories over the same period, with the change concentrated in the second half of the period

If more than four days have passed, skip the missed dose and take the next dose on the regularly scheduled day

Insurance coverage will vary by person and by insurance policy, and recently, more insurance plans have opted not to cover the cost of GLP-1 agonists, particularly those that are being prescribed for off-label use, Ngo-Hamilton says